BioSpace News Archive

Vaxart, Inc. (Nasdaq: VXRT) a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it plans to initiate the first Phase 2 study of its oral COVID-19 vaccine candidate, VXA-CoV2-1, in 2Q 2021.

Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2020.

Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, announced positive results from a comparative-effectiveness study have been published in JAMA Network Open.

Berkeley Lights, Inc., a leader in Digital Cell Biology, reported financial results for the fourth quarter and fiscal year ended December 31, 2020.

Supernus Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, reported financial results for the fourth quarter and full year of 2020, and associated Company developments.

Brickell Biotech, Inc. announced that Robert Brown, Brickell’s Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference and participate in a fireside chat at the Oppenheimer 31st Annual Healthcare Conference, which are both being held in March 2021.

Zynex, Inc., an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, reported financial results for its fourth quarter and full year ended December 31, 2020.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced financial results for the fourth quarter and full year ending December 31, 2020 and provided a corporate update.

Natera, Inc., a pioneer and global leader in cell-free DNA testing, reported financial results for the fourth quarter and year ended December 31, 2020 and provided an update on recent business progress.

Worldwide revenue of $94.2 million and $339.4 million for the fourth quarter and full year 2020, representing an increase of 5.4% and a decline of 2.3% over the prior year period, respectively